Get started
Author

Antonella Nardecchia

Observed names: A Nardecchia, A. NARDECCHIA, A. Nardecchia, NARDECCHIA, ANTONELLA
OpenAlex ID: A5108101248
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients
2014 · Vincenzo Formica, Jessica Luccchetti, et al. · Medical Oncology · 55
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma
2020 · V. Formica, C. Morelli, et al. · Critical Reviews in Oncology/Hematology · 27
Biological and predictive role of ERCC1 polymorphisms in cancer
2017 · V. Formica, E. Doldo, et al. · Critical Reviews in Oncology/Hematology · 23
PDF
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors
2020 · Vincenzo Formica, Cristina Morelli, et al. · Targeted Oncology · 19
Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and age
2021 · Vincenzo Formica, Antonella Nardecchia, et al. · Annals of Palliative Medicine · 18
PDF
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors
2021 · Giovanna Del Vecchio Blanco, Giampiero Palmieri, et al. · Scandinavian Journal of Gastroenterology · 18
PDF
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients
2015 · Raffaele Palmirotta, Silvia Riondino, et al. · Thrombosis and Haemostasis · 18
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases
2020 · Vincenzo Formica, Jessica Lucchetti, et al. · Journal of Clinical Medicine · 17
PDF
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin
2016 · Vincenzo Formica, Cristina Morelli, et al. · Cancer Biomarkers · 17
PDF
Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer
2021 · Giovanna Del Vecchio Blanco, Rami Dwairi, et al. · Internal and Emergency Medicine · 4
PDF
Gastric inflammatory prognostic index (GIPI) to predict efficacy of PD-1/PD-L1 immune checkpoint inhibitors in metastatic gastroesophageal junction (GOJ)/gastric cancer (GC) patients.
2020 · Cristina Morelli, Vincenzo Formica, et al. · Journal of Clinical Oncology · 2
Gastric Immune Prognostic Index (GIPI) in metastatic (m) gastro-oesophageal junction (GOJ)/gastric cancer (GC) patients (pts) treated with PD-1/PD-L1 immune checkpoint inhibitors (ICIs).
2020 · Cristina Morelli, Vincenzo Formica, et al. · Journal of Clinical Oncology · 2
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt
2018 · Vincenzo Formica, Michaela Benassi, et al. · Medical Oncology · 2
P-217 Value of liquid biopsy using high-affinity plasma DNA binding magnetic beads and qualitative real-time PCR for KRAS, NRAS and BRAF mutations in metastatic colorectal cancer patients
2020 · J. Lucchetti, V. Formica, et al. · Annals of Oncology
PDF
Factors Influencing Diagnostic Accuracy of Endoscopic Ultrasound With Fine Needle Aspiration (eus-fna) in Pancreato-biliary Tumors
2020 · E Troncone, C Cardamone, et al. · Endoscopy
A nomogram to predict neutropenia in metastatic pancreatic cancer patients treated with gemcitabine/nab-paclitaxel
2019 · C. Morelli, V. Formica, et al. · Annals of Oncology
A nomogram to predict poor health-related quality of life in metastatic colorectal cancer patients
2019 · V. Formica, A. Nardecchia, et al. · Annals of Oncology
PDF
Longitudinal assessment of neutrophil-to-lymphocyte ratio (NLR) from diagnosis until death reveals a biphasic trend in metastatic pancreatic adenocarcinoma patients
2018 · C. Morelli, V. Formica, et al. · Annals of Oncology
BMI and health-related quality of life (HR-QoL) in patients with metastatic colorectal cancer (mCRC).
2017 · Vincenzo Formica, Antonella Nardecchia, et al. · Journal of Clinical Oncology
Evaluation of QoL as a predictor of chemotherapy-induced toxicity
2017 · S. Mariotti, V. Formica, et al. · Annals of Oncology
Oc.01.4 Eus Predictive Factors of Recurrence in Patients With Local Advanced Rectal Cancer
2016 · E. Mannisi, V. Formica, et al. · Digestive and Liver Disease
Cisplatin plus capecitabine (CisCape) and concurrent pelvic radiotheapy for the neoadjuvant treatment of rectal cancer (RC)
2015 · V. Formica, L. Martano, et al. · Annals of Oncology
1571 Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy
2015 · V. Formica, S. Pellicori, et al. · European Journal of Cancer
P-323 Cisplatin plus capeitabine (CisCape) and radiotherapy (RT) for the neoadjuvant treatment of rectal cancer: final update of previously reported data
2015 · V. Formica, L. Martano, et al. · Annals of Oncology
PDF
Ideal Body Mass Index (BMI) difference between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy.
2015 · Vincenzo Formica, Stefania Pellicori, et al. · Journal of Clinical Oncology
Works count: 29
Citation count: 222
H-index: 9
I10-index: 9
Year
Topic
Type